The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Phenohytro
Phenobarbital, Hyoscyamine Sulfate, Atropine sulfate, and Scopolamine Hydrobromide · PHENOBARBITAL 16.2 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE .0194 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL · Elixir · Oral · Atlantic Biologicals Corp.
NDC 17856-0125-01 · 72 CUP, UNIT-DOSE in 1 BOX / 10 mL in 1 CUP, UNIT-DOSE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Phenobarbital, Hyoscyamine Sulfate, Atropine sulfate, and Scopolamine Hydrobromide (Elixir)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Atlantic Biologicals Corp. | PHENOBARBITAL 16.2 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE .0194 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Aug 26, 2026 | Sep 2, 2026 |
| Winder Laboratories LLC | PHENOBARBITAL 16.2 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE .0194 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Aug 26, 2026 | Aug 31, 2026 |
| Winder Laboratories LLC | PHENOBARBITAL .0194 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE 16.2 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Jul 22, 2026 | Aug 22, 2026 |
| Atlantic Biologicals Corp. | PHENOBARBITAL .0194 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE 16.2 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Jul 22, 2026 | Aug 19, 2026 |
| Atlantic Biologicals Corp. | ATROPINE SULFATE .0194 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; PHENOBARBITAL 16.2 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Jul 15, 2026 | Jul 15, 2026 |
| Winder Laboratories LLC | ATROPINE SULFATE .0194 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; PHENOBARBITAL 16.2 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Phenohytro — NDC 17856-0125-01," retrieved September 3, 2026, https://drugdashboards.com/drug/17856012501.
Free to cite with attribution — see how the data is put together.